Prevalence, incidence, and lifetime risk of atrial fibrillation in China: New insights into the global burden of atrial fibrillation

Chest

Volumn 147, Issue 1, 2015, Pages 109-119

  Guo, Yutao ^a   Tian, Yingchun ^b   Wang, Hao ^a   Si, Quanjin ^a   Wang, Yutang ^a   Lip, Gregory Y H ^c  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b Second People's Hospital   (China)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHINA; CHINESE; DISEASE DURATION; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; INCIDENCE; KAPLAN MEIER METHOD; LIFESPAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SCORING SYSTEM; SEX DIFFERENCE; ATRIAL FIBRILLATION; FOLLOW UP; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; YOUNG ADULT;

ADULT; ATRIAL FIBRILLATION; CHINA; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; YOUNG ADULT;

EID: 84920720354     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.14-0321     Document Type: Article

References (52)

1. Krijthe BP, Kunst A, Benjamin EJ, et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J. 2013; 34 (35): 2746-2751.
2. Lip GY, Brechin CM, Lane DA. The global burden of atrial fibrillation and stroke: a systematic review of the epidemiology of atrial fibrillation in regions outside North America and Europe. Chest. 2012; 142 (6): 1489-1498.
3. Colilla S, Crow A, Petkun W, Singer DE, Simon T, Liu X. Estimates of current and future incidence and prevalence of atrial fibrillation in the US adult population. Am J Cardiol. 2013 ;112(8):1142-1147.
4. Li Y, Wu YF, Chen KP, et al. Prevalence of atrial fibrillation in China and its risk factors. Biomed Environ Sci. 2013; 26 (9): 709-716.
5. Guo Y, Pisters R, Apostolakis S, et al. Stroke risk and suboptimal thromboprophylaxis in Chinese patients with atrial fibrillation: would the novel oral anticoagulants have an impact? Int J Cardiol. 2013; 168 (1): 515-522.
6. Heeringa J, van der Kuip DA, Hofman A, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J. 2006; 27 (8): 949-953.
7. Lloyd-Jones DM, Wang TJ, Leip EP, et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation. 2004; 110 (9): 1042-1046.
8. Zhou Z, Hu D. An epidemiological study on the prevalence of atrial fibrillation in the Chinese population of mainland China. J Epidemiol. 2008; 18 (5): 209-216.
9. Zhang X, Zhang S, Li Y, et al. Association of obesity and atrial fibrillation among middle-aged and elderly Chinese. Int J Obes (Lond). 2009; 33 (11): 1318-1325.
10. Long MJ, Jiang CQ, Lam TH, et al. Atrial fibrillation and obesity among older Chinese: the Guangzhou Biobank Cohort Study. Int J Cardiol. 2011; 148 (1): 48-52.
11. Mu HY, Qiu P, Lu WH, et al. Electrocardiogram Minnesota codings from 30 000 adult cases with Kazakh ethnicity in Xinjiang, China [in Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi. 2010 ;31(4);451-454
12. Kitamura A, Shimamoto T, Doi M, et al. Secular trends in prevalence and incidence of atrial fibrillation and associated factors in a Japanese rural population [in Japanese]. Nippon Koshu Eisei Zasshi. 1991; 38 (2): 95-105.
13. Ohsawa M, Okayama A, Okamura T, et al. Mortality risk attributable to atrial fibrillation in middle-aged and elderly people in the Japanese general population: nineteen-year follow-up in NIPPON DATA80. Circ J. 2007; 71 (6): 814-819.
14. Watanabe H, Watanabe T, Sasaki S, Nagai K, Roden DM, Aizawa Y. Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study. Am Heart J. 2009; 158 (4): 629-636.
15. Ohsawa M, Okayama A, Sakata K, et al. Rapid increase in estimated number of persons with atrial fibrillation in Japan: an analysis from national surveys on cardiovascular diseases in 1980, 1990 and 2000. J Epidemiol. 2005; 15 (5): 194-196.
16. Nakamura M, Endo H, Nasu M, Arakawa N, Segawa T, Hiramori K. Value of plasma Btype natriuretic peptide measurement for heart disease screening in a Japanese population. Heart. 2002; 87 (2): 131-135.
17. Ohsawa M, Itai K, Tanno K, et al. Cardiovascular risk factors in the Japanese northeastern rural population. Int J Cardiol. 2009; 137 (3): 226-235.
18. Inoue H, Fujiki A, Origasa H, et al. Prevalence of atrial fibrillation in the general population of Japan: an analysis based on periodic health examination. Int J Cardiol. 2009; 137 (2): 102-107.
19. Uchiyama S, Shibata Y, Hirabayashi T, et al; J-TRACE Investigators. Risk factor profiles of stroke, myocardial infarction, and atrial fibrillation: a Japanese Multicenter Cooperative Registry. J Stroke Cerebrovasc Dis. 2010; 19 (3): 190-197.
20. Iguchi Y, Kimura K, Aoki J, et al. Prevalence of atrial fibrillation in communitydwelling Japanese aged 40 years or older in Japan: analysis of 41,436 non-employee residents in Kurashiki-city. Circ J. 2008; 72 (6): 909-913.
21. Iguchi Y, Kimura K, Kobayashi K, et al. Relation of atrial fibrillation to glomerular filtration rate. Am J Cardiol. 2008; 102 (8): 1056-1059.
22. Kiatchoosakun S, Pachirat O, Chirawatkul A, Choprapawan C, Tatsanavivat P. Prevalence of cardiac arrhythmias in Thai community. J Med Assoc Thai. 1999; 82 (7): 727-733.
23. Assantachai P, Panchavinnin P, Pisalsarakij D. An electrocardiographic survey of elderly Thai people in the rural community. J Med Assoc Thai. 2002; 85 (12): 1273-1279.
24. Yap KB, Ng TP, Ong HY. Low prevalence of atrial fibrillation in communitydwelling Chinese aged 55 years or older in Singapore: a population-based study. J Electrocardiol. 2008; 41 (2): 94-98.
25. Kaushal SS, Das Gupta DJ, Prashar BS, Bhardwaj AK. Electrocardiographic manifestations of healthy residents of a tribal Himalayan village. J Assoc Physicians India. 1995; 43 (1): 15-16.
26. Freestone B, Rajaratnam R, Hussain N, Lip GY. Admissions with atrial fibrillation in a multiracial population in Kuala Lumpur, Malaysia. Int J Cardiol. 2003; 91 (2-3): 233-238.
27. Society of Cardiology, Chinese Medical Association. Retrospective investigation of hospitalized patients with atrial fibrillation in mainland China. Chin Med J (Engl). 2004; 117 (12): 1763-1767.
28. Tomita F, Kohya T, Sakurai M, et al; Hokkaido Atrial Fibrillation Study Group. Prevalence and clinical characteristics of patients with atrial fibrillation: analysis of 20,000 cases in Japan. Jpn Circ J. 2000; 64 (9): 653-658.
29. Suzuki S, Yamashita T, Ohtsuka T, et al. Body size and atrial fibrillation in Japanese outpatients. Circ J. 2010; 74 (1): 66-70.
30. Suzuki S, Yamashita T, Ohtsuka T, et al. Prevalence and prognosis of patients with atrial fibrillation in Japan: a prospective cohort of Shinken Database 2004. Circ J. 2008; 72 (6): 914-920.
31. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991; 22 (8): 983-988.
32. Friberg J, Scharling H, Gadsbøll N, Truelsen T, Jensen GB; Copenhagen City Heart Study. Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (The Copenhagen City Heart Study). Am J Cardiol. 2004; 94 (7): 889-894.
33. Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the longterm risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med. 2002; 113 (5): 359-364.
34. Stewart S, Hart CL, Hole DJ, McMurray JJ. Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study. Heart. 2001; 86 (5): 516-521.
35. Rietbrock S, Heeley E, Plumb J, van Staa T. Chronic atrial fibrillation: Incidence, prevalence, and prediction of stroke using the Congestive heart failure, Hypertension, Age. > 75, Diabetes mellitus, and prior Stroke or transient ischemic attack (CHADS2) risk stratification scheme. Am Heart J. 2008; 156 (1): 57-64.
36. Hobbs FD, Fitzmaurice DA, Mant J, et al. A randomised controlled trial and costeffectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study. Health Technol Assess. 2005; 9 (40): 1-74.
37. Schmutz M, Beer-Borst S, Meiltz A, et al. Low prevalence of atrial fibrillation in asymptomatic adults in Geneva, Switzerland. Europace. 2010; 12 (4): 475-481.
38. Andersson P, Löndahl M, Abdon NJ, Terent A. The prevalence of atrial fibrillation in a geographically well-defined population in northern Sweden: implications for anticoagulation prophylaxis. J Intern Med. 2012; 272 (2): 170-176.
39. Stefansdottir H, Aspelund T, Gudnason V, Arnar DO. Trends in the incidence and prevalence of atrial fibrillation in Iceland and future projections. Europace. 2011; 13 (8): 1110-1117.
40. Ohlmeier C, Mikolajczyk R, Haverkamp W, Garbe E. Incidence, prevalence, and antithrombotic management of atrial fibrillation in elderly Germans. Europace. 2013; 15 (10): 1436-1444.
41. Tse HF, Wang YJ, Ahmed Ai-Abdullah M, et al. Stroke prevention in atrial fibrillation-an Asian stroke perspective. Heart Rhythm. 2013; 10 (7): 1082-1088.
42. Guo Y, Lip GY, Apostolakis S. The challenge of antiplatelet therapy in patients with atrial fibrillation and heart failure. J Cardiovasc Transl Res. 2013; 6(3): 388-397.
43. Kakkar AK, Mueller I, Bassand JP, et al; GARFIELD Registry Investigators. Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry. PLoS ONE. 2013; 8 (5): e63479.
44. Go AS, Hylek EM, Borowsky LH, Phillips KA, Selby JV, Singer DE. Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Ann Intern Med. 1999; 131 (12): 927-934.
45. Gladstone DJ, Bui E, Fang J, et al. Potentially preventable strokes in highrisk patients with atrial fibrillation who are not adequately anticoagulated. Stroke. 2009; 40 (1): 235-240.
46. Chien KL, Su TC, Hsu HC, et al. Atrial fibrillation prevalence, incidence and risk of stroke and all-cause death among Chinese. Int J Cardiol. 2010; 139 (2): 173-180.
47. Lee CH, Liu PY, Tsai LM, et al. Characteristics of hospitalized patients with atrial fibrillation in Taiwan: a nationwide observation. Am J Med. 2007 ;120(9):819.e1-7.
48. Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006; 114 (2): 119-125.
49. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med. 1995; 98 (5): 476-484.
50. Ruigómez A, Johansson S, Wallander MA, Rodríguez LA. Incidence of chronic atrial fibrillation in general practice and its treatment pattern. J Clin Epidemiol. 2002; 55 (4): 358-363.
51. Alonso A, Krijthe BP, Aspelund T, et al. Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium. J Am Heart Assoc. 2013 ;2(2):e000102.
52. Guo Y, Apostolakis S, Blann AD, et al. Validation of contemporary stroke and bleeding risk stratification scores in non-anticoagulated Chinese patients with atrial fibrillation. I nt J Cardiol. 2013; 168 (2): 904-909.